Effect of dexamethasone therapy on serum vitamin E concentrations in premature infants with bronchopulmonary dysplasia

Journal of Perinatology

Volumn 23, Issue 7, 2003, Pages 552-555

  Amin, Sanjiv B ^a,b,d   Laroia, Nirupama ^a   Sinkin, Robert A ^a   Kendig, James W ^a,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c PENN STATE CHILDREN S HOSPITAL   (United States)

^d University Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DEXAMETHASONE; LIPID; STEROID; TRIACYLGLYCEROL;

CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG MECHANISM; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTRIGLYCERIDEMIA; INFANT; LIPID BLOOD LEVEL; LUNG DYSPLASIA; MALE; PREMATURITY; PROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

BRONCHOPULMONARY DYSPLASIA; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; TRIGLYCERIDES; VITAMIN E;

EID: 0242456057     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210984     Document Type: Review

References (22)

1. Ehrenkranz RA. Vitamin E and the neonate. Am J Dis Child 1980;134: 1157-66.
2. Hittner HM, Godio LB, Rudolph AJ et al. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N Engl J Med 1981;305:1365-71.
3. Johnson L, Quinn GE, Abbasi S, Gerdes J, Bowen FW, Bhutani V. Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacological serum levels of vitamin E in addition to cryotherapy from 1985 to 1991. J Pediatr 1995;127(4):632-39.
4. Milner RA, Watts JL, Paes B, Zipursky A. RLF in <1500 gram Neonates. Part of a Randomized Clinical Trial of the Effectiveness of Vitamin E. Retinopathy of Prematurity Conference. Columbus, OH: Ross Laboratories; 1981. p. 703-16.
5. Finer NN, Schindler RF, Grant G, Hill GB, Peters KL. Effect of intramascular vitamin E on frequency and severity of retrolental fibroplasias. A controlled trial. Lancet 1982;1:1087-91.
6. Puklin JE, Simon RM, Ehrenkranz RA. Influence on retrolental fibroplasias of intramuscular vitamin E administration during respiratory distress syndrome. Opthalmology 1982;89:96-103.
7. Phelps DL, Rosenbaum AL, Isenberg SJ, Leake RD, Dorey FJ. Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial. Pediatrics 1987;79: 489-500.
8. Johnson L, Quinn GE, Abbasi S et al. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. J Pediatr 1989;114:827-38.
9. Raju TNK, Langenberg P, Bhutani V, Quinn GE. Vitamin E prophylaxis to reduce retinopathy of prematurity. A reappraisal of published trials. J Pediatr 1997;131(6):844-50.
10. Rotschild T, Nandgaonkar BN, Yu K, Higgins RD. Dexamethasone reduces oxygen induced retinopathy in a mouse model. Pediatr Res 1999;46(1): 94-100.
11. Ramanathan R, Siassi B, deLemos RA. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy. J Perinatol 1995;15(3):178-82.
12. Cuculich PS, DeLozier KA, Mellen BG, Shenai JP. Postnatal dexamethasone treatment and retinopathy of prematurity in very-low-birth weight neonates. Biol Neonate 2001; 79(1):9-14.
13. Yossuck P, Yan Y, Tadesse M, Higgins RD. Dexamethasone and critical effect of timing on retinopathy. Invest Ophthalmol Vis Sci 2000; 41(10):3095-9.
14. Georgieff MK, Mammel MC, Mills MM, Gunter EW, Johnson DE, Thompson TR. Effect of postnatal steroid administration on serum vitamin A concentrations in newborn infants with respiratory compromise. J Pediatr 1989;114(2):301-4.
15. Shenai JP, Mellen BG, Chytil F. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia. Pediatrics 2000;106(3):547-53.
16. Amin SB, Sinkin RA, McDermott MP, Kendig JW. Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia. Arch Pediatr Adolesc Med 1999;153(8):795-800.
17. Avery GB, Fletcher AB, Kaplan M, Spencer Brudno D. Controlled trial of dexamethasone in respiratory-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;75(1):106-11.
18. Bieri JG, Poukka R, Thorp S. Factors affecting the exchange of tocopherol between red blood cells and plasma. Am J Clin Nutr 1977;30:686-90.
19. Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M. The use of different lipids to express serum tocopherol:lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 1986;23:514-20.
20. Farrell PM, Levin SL, Murphey MD, Adams AJ. Plasma tocopherol levels and tocopherol-lipid relationships in a normal population of children as compared to healthy adults. Am J Clin Nutr 1978;31:1720.
21. Walerius G, Dollberg S, Mimouni F, Doyle J, Gilmour C. Effect of pulsed dexamethasone therapy on tolerance to intravenously administered lipids in extremely low birth weight infants. J Pediatr 1999;134(2):229-32.
22. Farrell PM. Vitamin E deficiency in premature infants. J Pediatr 1979;95(5):869-72.